glp-1 agonist constipation Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Managing GI Discomfort on GLP-1s:
Description
Most are injectable medications, although one oral formulation is currently available
Additionally, fatigue emerged as a frequently discussed symptom, despite being less prominent in clinical trial data
This analysis also indicated fewer acute kidney injuries with the use of SGLT2 inhibitors
VrintsCAndreottiFKoskinasKCRosselloXAdamoMAinslieJet al2024 ESC guidelines for the management of chronic coronary syndromes
2.3 Neuroinflammation and cognitive dysfunction in diabetes Diabetes, as a chronic metabolic disorder, induces a chronic inflammatory state that damages the central nervous system
2023 [citato 29 giugno 2024]
